We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ISSUES WARNINGS TO STEROID MANUFACTURERS
FDA ISSUES WARNINGS TO STEROID MANUFACTURERS
March 11, 2004
After issuing a final rule earlier this year banning dietary supplements containing ephedra, the FDA focused its efforts yesterday on taking the steroid precursor androstenedione, also known as andro, off the market by issuing warning letters to 23 companies manufacturing and distributing andro products.